Sun Pharma set to commercialise acne cream in US, Canada

Sun Pharma and Cassiopea SPA on Tuesday announced consummation of their exclusive licence and supply agreements for Winlevi cream used for treatment of acne vulgaris in patients 12 years and older. The agreements are effective from August 31, 2021, according to a joint statement. Cassiopea will be the exclusive supplier of the product.